(Q34691239)

4 August 2017

1 reference

title

Pathologically activated therapeutics for neuroprotection (English)

1 reference

4 August 2017

Stuart A Lipton

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Nature Reviews Neuroscience

4 August 2017

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

10

1 reference

4 August 2017

page(s)

803-808

1 reference

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

4 August 2017

cites work

1 reference

Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits

21 January 2018

1 reference

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

21 January 2018

1 reference

Emerging treatments for stroke in humans

31 March 2020

1 reference

NMDA receptor pathways as drug targets

31 March 2020

1 reference

Turning down, but not off.

31 March 2020

1 reference

Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine

31 March 2020

1 reference

Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state

31 March 2020

1 reference

Neurophysiology: stressful pacemaking

31 March 2020

1 reference

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

31 March 2020

1 reference

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

31 March 2020

1 reference

Excitatory amino acids as a final common pathway for neurologic disorders.

31 March 2020

1 reference

Glutamate neurotoxicity and diseases of the nervous system

31 March 2020

1 reference

Excitatory amino acid neurotoxicity and neurodegenerative disease

31 March 2020

1 reference

Pathways towards and away from Alzheimer's disease

31 March 2020

1 reference

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

31 March 2020

1 reference

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

31 March 2020

1 reference

New perspectives on glaucoma

31 March 2020

1 reference

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

31 March 2020

1 reference

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

31 March 2020

1 reference

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

31 March 2020

1 reference

NMDA receptors, glial cells, and clinical medicine

31 March 2020

1 reference

The chemical biology of clinically tolerated NMDA receptor antagonists

31 March 2020

1 reference

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

31 March 2020

1 reference

Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain

31 March 2020

1 reference

Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain

31 March 2020

1 reference

NR3A modulates the outer vestibule of the "NMDA" receptor channel

31 March 2020

1 reference

Protein S-nitrosylation: purview and parameters

31 March 2020

1 reference

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

31 March 2020

1 reference

Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation

31 March 2020

1 reference

Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex

31 March 2020

1 reference

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

31 March 2020

1 reference

Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-.

31 March 2020

1 reference

Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif

31 March 2020

1 reference

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

31 March 2020

1 reference

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

31 March 2020

1 reference

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

31 March 2020

1 reference

A conserved family of prolyl-4-hydroxylases that modify HIF

31 March 2020

1 reference

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

31 March 2020

1 reference

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

31 March 2020

1 reference

New avenues of exploration for erythropoietin

31 March 2020

1 reference

Emerging biological roles for erythropoietin in the nervous system

31 March 2020

1 reference

Erythropoietin for neurologic protection and diabetic neuropathy

31 March 2020

1 reference

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

31 March 2020

1 reference

Erythropoietin: structure, control of production, and function

31 March 2020

1 reference

Localization of specific erythropoietin binding sites in defined areas of the mouse brain

31 March 2020

1 reference

Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain

31 March 2020

1 reference

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

31 March 2020

1 reference

Erythropoietin therapy for acute stroke is both safe and beneficial

31 March 2020

1 reference

Potent mechanism-based inhibitors for matrix metalloproteinases

31 March 2020

1 reference

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

31 March 2020

1 reference

A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

31 March 2020

1 reference

Metalloproteinases in biology and pathology of the nervous system.

31 March 2020

1 reference

Metalloproteinases: mediators of pathology and regeneration in the CNS.

31 March 2020

1 reference

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

31 March 2020

1 reference

Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.

31 March 2020

1 reference

Matrix metalloproteinases and free radicals in cerebral ischemia

31 March 2020

1 reference

Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic

31 March 2020

1 reference

Matrix Metalloproteinase Expression After Human Cardioembolic Stroke

31 March 2020

1 reference

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

31 March 2020

1 reference

Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

31 March 2020

1 reference

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

31 March 2020

1 reference

Matrix metalloproteinases increase very early during experimental focal cerebral ischemia

31 March 2020

1 reference

Role of matrix metalloproteinases in delayed cortical responses after stroke.

31 March 2020

1 reference

Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers

31 March 2020

1 reference

Redox regulation of neuronal survival mediated by electrophilic compounds

31 March 2020

1 reference

Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles

31 March 2020

1 reference

Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

31 March 2020

1 reference

A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.

31 March 2020

1 reference

Molecular mechanisms of local anesthesia: a review

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN2229

1 reference

Dimensions Publication ID

4 August 2017

1025114625

0 references

1 reference